Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: micardis

« Back to Dashboard

Summary for Tradename: micardis

Patents:4
Applicants:1
NDAs:2
Suppliers: see list4

Pharmacology for Tradename: micardis

Clinical Trials for: micardis

CKD-828 Drug Interaction Study (Telmisartan)
Status: Completed Condition: Healthy Male Volunteers

Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
Status: Completed Condition: Hypertension

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
Status: Completed Condition: Stroke

Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male Volunteers
Status: Completed Condition: Healthy

Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients
Status: Completed Condition: Inflammation; End-stage Renal Disease

Telmisartan, Amlodipine and Combination in Healthy Subjects
Status: Completed Condition: Healthy

CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)
Status: Completed Condition: Hypertension; Hyperlipidemia

Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine
Status: Completed Condition: Essential Hypertension; Hyperlipidemia

CKD-828 (80/5mg) Pharmacokinetic Study
Status: Not yet recruiting Condition: Hypertension

Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease
Status: Recruiting Condition: Nonalcoholic Fatty Liver Disease (NAFLD)

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim
MICARDIS
telmisartan
TABLET;ORAL020850Nov 10, 1998RXNo6,358,986<disabled><disabled>
Boehringer Ingelheim
MICARDIS
telmisartan
TABLET;ORAL020850Apr 4, 2000RXNo5,591,762<disabled><disabled>
Boehringer Ingelheim
MICARDIS HCT
hydrochlorothiazide; telmisartan
TABLET;ORAL021162Apr 19, 2004RXYes5,591,762<disabled>YY<disabled>
Boehringer Ingelheim
MICARDIS
telmisartan
TABLET;ORAL020850Nov 10, 1998RXYes6,358,986<disabled><disabled>
Boehringer Ingelheim
MICARDIS HCT
hydrochlorothiazide; telmisartan
TABLET;ORAL021162Nov 17, 2000RXNo5,591,762<disabled>YY<disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: MICARDIS

Drugname Dosage Strength RLD Submissiondate
telmisartan and hydrochlorothiazideTablets80 mg/25 mgMicardis HCT2/27/2009
telmisartan and hydrochlorothiazideTablets80 mg/12.5 mg and 40 mg/12.5 mgMicardis HCT12/31/2008
telmisartanTablets20 mg, 40 mg and 80 mgMicardis12/26/2006
« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc